MEPRIMET VG1 PLUS TABLET

Product Description

MEPRIMET VG1 PLUS TABLET is a triple-action anti-diabetic formulation designed to provide comprehensive glycemic control in patients with Type 2 Diabetes Mellitus. Combining Glimepiride 1mg, Metformin 500mg, and Voglibose 0.3mg, this tablet targets insulin resistance, enhances insulin secretion, and delays glucose absorptionmaking it a powerful solution for managing postprandial and fasting blood sugar levels.Manufactured under WHO-GMP certified facilities, MEPRIMET VG1 PLUS is ideal for hospital chains, retail pharmacies, and B2B pharma distributors seeking a high-demand, effective diabetes management solution.Key Benefits: Triple-drug combination ensures synergistic glucose control Reduces post-meal sugar spikes and improves insulin sensitivity Cost-effective therapy with high patient adherence Manufactured with strict quality control standards Applications: First-line treatment for Type 2 Diabetes Mellitus Widely prescribed in endocrinology, general medicine, and diabetic care clinics Suitable for long-term blood sugar management Why Choose MEPRIMET VG1 PLUS TABLET? Clinically effective and doctor-recommended formula In-demand product for pharma wholesalers and distributors Ready stock available for large-scale and institutional supply